Definitive Contract 75N91018C00039
Award Date 9/12/18
Potential Completion Date 3/31/22
Potential Value $2.3M
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
La Costa, CA 92009, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
11
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Cancer Institute awarded a firm fixed-price purchase order to CN Consulting LLC (UEI: LBK1L1H32HR7) on September 16, 2024, with a ceiling value of $25,391.66. This contract, designated as a Total Small Business set-aside, supports specialized subject matter expert services for the Cancer Moonshot 1.0 Initiative, a one-time federal effort designed to accelerate progress in cancer research and treatment. The work is being performed in Bethesda, Maryland, with an ultimate completion...
- This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute (NCI) to Inlighta Biosciences L.L.C., a woman-owned small business. The $298,230.00 firm fixed-price contract is for a Phase I Small Business Innovation Research (SBIR) project titled "Non-Invasive Subtyping of Aggressive Tumor and Its Environment" as part of the NCI Cancer Moonshot initiative. The original solicitation was issued under the NIH/CDC...
- This definitive contract for $1,345,018 was awarded by the National Cancer Institute, a component of the Department of Health and Human Services, to Biomarker Strategies LLC of Derwood, Maryland. The contract is associated with Small Business Innovation Research Program Phase II funding and supports the development of a novel predictive test for response to combination immunotherapies for patients with non-small cell lung cancer. The firm fixed price contract has a completion date of August...
- This is a $355,000.00 Firm Fixed Price definitive contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Immunotarget Therapeutics Inc., a woman-owned small business. The contract is for the NCI's Small Business Innovation Research (SBIR) Innovative Concept Award program, which seeks proposals for highly innovative therapies, diagnostic tools, or preventive strategies focused on pediatric and/or rare cancers. The...
- This is a $1,484,350.00 Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Shuttle Pharmaceuticals, Inc., a small business Subchapter S Corporation. The contract is for cell-based models for prostate cancer health disparity research as part of the Cancer Moonshot program (Phase II). The contract has a total small business set aside designation and an ultimate completion date of November 16, 2021. This award builds upon a previous contract with...
- This $399,951 firm-fixed-price definitive contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to the small business Care Progress LLC. The contract supports the development of "BIOMARKERAWARE: A NOVEL SYSTEM TO IMPROVE PRECISION ONCOLOGY" under the NCI's Small Business Innovation Research (SBIR) program, which is a set-aside for small businesses. Care Progress LLC, a for-profit limited liability company, has previously...
- This definitive firm fixed price contract from the Department of Health and Human Services National Institutes of Health National Cancer Institute, with a total small business set aside, is for $299,726.89 to Imago Systems Inc. for the development of a novel diagnostic imaging modality for monitoring tumor responses to a hyperthermia immunotherapy as part of the National Cancer Institute's Moonshot initiative. The award stems from Topic 375 of the NIH/CDC SBIR Contract Solicitation PHS 2018-1,...
- This contract was awarded by the National Cancer Institute (NCI), a civilian agency, to the small business prime contractor Columbus Nanoworks, Inc. The $299,999 Firm Fixed Price contract is for the SBIR Phase I research and development of "Imaging for Cancer Immunotherapies-Moonshot," which is focused on advancing imaging technologies to support cancer immunotherapies. The work is being performed in Grandview, Ohio. Columbus Nanoworks is a for-profit biotechnology research company...
- Leidos Biomedical Research Inc., a Federally Funded Research and Development Center (FFRDC) subsidiary of Leidos Holdings, Inc., was awarded a delivery order valued at $19.76 million by the National Cancer Institute on September 28, 2017, for the Retrospective Tumor Characterization Analysis (Moonshot) initiative. This cost-plus-fixed-fee delivery order, with an ultimate completion date of September 30, 2026, supports the National Cancer Institute's cancer research mission and will be...
- This definitive contract was awarded by the National Institutes of Health National Cancer Institute to Avantgen Inc. for $299,854 to develop and validate non-mouse reagents to enable preclinical development of novel therapeutics under the Small Business Innovation Research Program Phase I solicitation. The contract responds to the research topic "Development and Validation of Non-Mouse Reagents to Enable Preclinical Development of Novel Therapeutics" listed in the NIH/CDC SBIR Contract...